Royal Bank of Canada’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,009
| Closed | -$112K | – | 8201 |
|
|
2022
Q1 | $112K | Sell |
4,009
-106,476
| -96% | -$2.92M | ﹤0.01% | 5571 |
|
|
2021
Q4 | $3.02M | Buy |
110,485
+17,086
| +18% | +$463K | ﹤0.01% | 2792 |
|
|
2021
Q3 | $2.54M | Buy |
93,399
+84,619
| +964% | +$2.09M | ﹤0.01% | 2870 |
|
|
2021
Q2 | $150K | Buy |
8,780
+558
| +7% | +$10.4K | ﹤0.01% | 5310 |
|
|
2021
Q1 | $171K | Buy |
8,222
+1,430
| +21% | +$33K | ﹤0.01% | 5073 |
|
|
2020
Q4 | $155K | Buy |
6,792
+94
| +1% | +$1.79K | ﹤0.01% | 5049 |
|
|
2020
Q3 | $110K | Sell |
6,698
-45
| -0.7% | -$815 | ﹤0.01% | 4914 |
|
|
2020
Q2 | $91K | Buy |
6,743
+436
| +7% | +$5.07K | ﹤0.01% | 4907 |
|
|
2020
Q1 | $75K | Sell |
6,307
-1,846
| -23% | -$40.9K | ﹤0.01% | 4942 |
|
|
2019
Q4 | $203K | Sell |
8,153
-5,115
| -39% | -$104K | ﹤0.01% | 4632 |
|
|
2019
Q3 | $226K | Sell |
13,268
-291
| -2% | -$5.3K | ﹤0.01% | 4378 |
|
|
2019
Q2 | $309K | Sell |
13,559
-893
| -6% | -$24.1K | ﹤0.01% | 4187 |
|
|
2019
Q1 | $465K | Buy |
14,452
+6,631
| +85% | +$205K | ﹤0.01% | 3774 |
|
|
2018
Q4 | $220K | Sell |
7,821
-197,139
| -96% | -$5.77M | ﹤0.01% | 4293 |
|
|
2018
Q3 | $5.89M | Sell |
204,960
-10,119
| -5% | -$304K | ﹤0.01% | 1999 |
|
|
2018
Q2 | $8.05M | Buy |
215,079
+99,976
| +87% | +$3.92M | ﹤0.01% | 1677 |
|
|
2018
Q1 | $4.52M | Buy |
115,103
+86,239
| +299% | +$3.15M | ﹤0.01% | 2057 |
|
|
2017
Q4 | $935K | Buy |
28,864
+11,852
| +70% | +$355K | ﹤0.01% | 3280 |
|
|
2017
Q3 | $530K | Sell |
17,012
-1,014
| -6% | -$30K | ﹤0.01% | 3745 |
|
|
2017
Q2 | $504K | Sell |
18,026
-2,334
| -11% | -$52.8K | ﹤0.01% | 3653 |
|
|
2017
Q1 | $349K | Sell |
20,360
-848
| -4% | -$11.9K | ﹤0.01% | 3928 |
|
|
2016
Q4 | $256K | Buy |
21,208
+1,858
| +10% | +$24.1K | ﹤0.01% | 4321 |
|
|
2016
Q3 | $307K | Sell |
19,350
-27,000
| -58% | -$407K | ﹤0.01% | 4117 |
|
|
2016
Q2 | $599K | Buy |
46,350
+46,250
| +46,250% | +$724K | ﹤0.01% | 3544 |
|
|
2016
Q1 | $2K | Sell |
100
-713
| -88% | -$12.9K | ﹤0.01% | 6156 |
|
|
2015
Q4 | $18K | Sell |
813
-6,093
| -88% | -$120K | ﹤0.01% | 5761 |
|
|
2015
Q3 | $161K | Buy |
6,906
+2,036
| +42% | +$56.2K | ﹤0.01% | 4482 |
|
|
2015
Q2 | $139K | Buy |
4,870
+757
| +18% | +$19.8K | ﹤0.01% | 4632 |
|
|
2015
Q1 | $106K | Buy |
4,113
+4,055
| +6,991% | +$92.7K | ﹤0.01% | 4592 |
|
|
2014
Q4 | $1K | Buy |
+58
| New | +$1.04K | ﹤0.01% | 6071 |
|
Royal Bank of Canada's XENT Position: Q2 2022 in Review
Royal Bank of Canada sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 4,009 shares — an estimated $112K sold.
Royal Bank of Canada first reported a position in XENT in Q4 2014 and held it in 30 quarters. The position peaked at $8.05M in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Royal Bank of Canada reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Royal Bank of Canada sold 4,009 Intersect ENT, Inc shares in Q2 2022, an estimated $112K.
- Royal Bank of Canada first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 30 quarters.
- Royal Bank of Canada's Intersect ENT, Inc position peaked at $8.05M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.